Alcon Inc. vs Abbvie Inc.
ALC vs ABBV — side-by-side comparison from reported financials. ALC leads 6, ABBV leads 6 of 12 comparable metrics.
Alcon Inc.
ALC · Healthcare
$64.11+1.55%Strong
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | ALC | ABBV |
|---|---|---|
| Price | $64.11 | $276.43 |
| Market cap | $31.0B | $488B |
| Revenue (TTM) | $10.4B | $64.4B |
| Revenue growth | +6.1% | +1.8% |
| Net margin | 9.4% | 9.8% |
| Free cash flow | $1.74B | $18.2B |
| Net cash (debt) | ($3.84B) | ($56.2B) |
| 1-year price return | -14.0% | +19.8% |
| P/E | 38.4 | 77.4 |
| P/E vs own history (cheap-side %) | 99% | 23% |
| Dividend yield | 0.55% | 2.45% |
| Return on equity | 3% | 96% |
| Altman Z-score | 2.56 | 2.33 |
| CV checks passed | 11 of 11 | 9 of 11 |
| Employees | 25,942 | 57,000 |
Full résumé-style profiles: ALC CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.